events affect agricultural production and farm prices – the main source of income for the majority of Thai people – and thus have repercussions for businesses dependent mainly on domestic consumption
) attributable to Equity holders of the Company 22.01 13.69 22.82 13.69 Total revenues of the company and the company’s subsidiaries in the consolidated financial statements for the 3 months period end of 31st
clarify the operating results for Q2/2018 as follows: From the Consolidated Financial Statements for the 2nd quarter of 2018 ending June 30, 2018, the Company had operating profit of the equity holders of
Company Limited would like to clarify for Quarter 1/2018 based on the company financial statement. The main items were as followed: Unit : Million Baht 2018 2017 %Increased (Decreased) Total Revenues 260.26
sales volumes plus greater main raw material costs from higher crude oil price and tight market supply. However, the overall spread margin was improved and bring 23.9% gross profit margin comparing to
profit margin was slightly brought down by 0.9% of gross profit margin due to turnaround costs and the rise of main raw material prices from tight supply plus greater crude oil prices. 2. In Q2 2018
partially offset by higher sales volume of all main products as a result of stable operation. Analysis of Cost and Expenses 1. In Q3 2019, Cost of sales was 3,445 MTHB, decreased by 715 MTHB comparing to 2018
well as attending Chinese fertility centers which is the main user group of the subsidiary company. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of THB
September 30, 2018, the Company had operating profit of the equity holders of THB 7.48 million, a decrease of THB 23.55 million or 75.89 per cent, compared to the same quarter in 2017. The main reason is as
company still has foreign exchange gains compared to US dollars. (Which is the main trading currency of the company) Cost of Sales for Q3 / 2020 and Q3 / 2019 was 347.60 million baht and 357.94 million baht